Drug Type TCR-T Cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| KRAS mutant Non-small Cell Lung Cancer | IND Approval | China | 23 Dec 2025 | |
| KRAS Mutant Pancreatic Cancer | IND Approval | China | 23 Dec 2025 | |
| Colorectal Cancer | IND Application | China | - |





